Intrahepatic HBV DNA as a predictor of antivirus treatment efficacy in HBeAg-positive chronic hepatitis B patients

AIM: To evaluate the effect of antiviral agents on intrahepatic HBV DNA in HBeAg-positive chronic hepatitis B patients. METHODS: Seventy-one patients received treatment with lamivudine, interferon alpha (IFN-α2b) or sequential therapy with lamivudine-IFN-α2b for 48 wk. All subjects were followed up...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:World J Gastroenterol
Autores principales: Lu, Hai-Ying, Zhuang, Li-Wei, Yu, Yan-Yan, Ivan, Hadad, Si, Chong-Wen, Zeng, Zheng, Li, Jun, Hou, Dong-Ming, Chen, Xin-Yue, Han, Zhong-Hou, Chen, Yong
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Co., Limited 2007
Materias:
Rapid Communication
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4395644/
https://ncbi.nlm.nih.gov/pubmed/17569128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v13.i20.2878
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares